Close Menu

By Monica Heger

Diagnostic company
Asuragen has entered the next-generation sequencing space with targeted cancer panels for the Ion Torrent PGM and Illumina Genome Analyzer. The panels have been optimized to work on DNA extracted from formalin-fixed paraffin-embedded tissue as well as tissue extracted by fine needle aspiration.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more.